English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Researchers develop scSurv method to link single cells with patient outcomes
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Study highlights neurological and psychiatric impacts of long COVID
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Study finds similar healthy life years for older adults in Japan and Sweden
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

New cholesterol guidelines emphasize earlier risk assessment and prevention
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Virtual reality headsets provide real-world training for radiography students
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Japan’s drug pricing policies discussed in White House meeting with Prime Minister Takaichi
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Gilead Sciences announces $2.1 billion acquisition deal for Ouro Medicines
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Gilead CEO Daniel O’Day receives 20% pay increase to $28.44 million in 2025

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes